These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4896330)

  • 21. Characteristics of disparate histocompatibility barriers in congenic strains of mice. II. Antibody-associated suppression.
    Cantrell JL; Hildemann WH
    J Immunol; 1973 Mar; 110(3):629-36. PubMed ID: 4143981
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of the histocompatibility-2 (H-2) locus of NZB mice.
    Klein J; Martínková J; Herzenberg LA
    Transplantation; 1967 Sep; 5(5):1335-8. PubMed ID: 4861924
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor metastasis in mice with reduced immune reactivity. II. Studies with a highly antigenic MCA-induced sarcoma in thymectomized and/or sub-lethally irradiated C57BL/6J mice.
    Suurküla M; Boeryd B
    Int J Cancer; 1974 Nov; 14(5):633-41. PubMed ID: 4376529
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The problem of histocompatibility in wild hamsters.
    Palm J; Silvers WK; Billingham RE
    J Hered; 1967; 58(1):40-4. PubMed ID: 5340181
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific unresponsiveness to skin allografts in mice. I. Properties of tissue extracts and their synergistic effect with antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ; Thomas AV
    Transplantation; 1973 Jan; 15(1):160-71. PubMed ID: 4575919
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect, according to dose, of the pretreatment of mouse recipients of skin homografts by lipoprotein, water-soluble and purified H2 antigen, preparations].
    Florentin I
    Rev Fr Etud Clin Biol; 1969; 14(7):690-3. PubMed ID: 4901304
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of antitumor action of polysaccharide fraction prepared from bagasse. II. Immunological reactivity of mice and properties of their sera.
    Tanaka T
    Gan; 1967 Oct; 58(5):451-7. PubMed ID: 4866946
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure of 6-mercaptopurine to prolong the survival of skin allografts in mice.
    Stewart PB
    Transplantation; 1969 Jun; 7(6):498-505. PubMed ID: 4893038
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanism of immunological enhancement of H-2-incompatible skin grafts in mice.
    Chutná J
    Transplantation; 1971 Jul; 12(1):28-35. PubMed ID: 4932695
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies].
    Brondz BD
    Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605
    [No Abstract]   [Full Text] [Related]  

  • 33. Survival of transplanted spleen cells in allogeneic mice. The effects of strength of histoincompatibility and of C' deficiency.
    Salerno A
    Transplantation; 1969 Aug; 8(2):189-93. PubMed ID: 5804783
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological aspects of resistance to the oncogenic effect of 3-methylcholanthrene in mice.
    Stutman O
    Isr J Med Sci; 1973 Mar; 9(3):217-28. PubMed ID: 4575650
    [No Abstract]   [Full Text] [Related]  

  • 35. Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma.
    Moore M; Williams DE
    Int J Cancer; 1973 Mar; 11(2):358-68. PubMed ID: 4790698
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens.
    Law LW; Appella E; Wright PW; Strober S
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3078-82. PubMed ID: 4108871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological responses of mice during active enhancement of tumour allografts.
    Mildenhall P; Nelson DS
    Br J Exp Pathol; 1968 Apr; 49(2):170-8. PubMed ID: 5646469
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of repeated injections of strong cell-free histocompatibility antigens on graft survival and runt disease in mice.
    Haller JA; Rodgers BM
    Johns Hopkins Med J; 1967 Dec; 121(6):393-400. PubMed ID: 4863154
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on histocompatibility in skin allotransplantaion in rabbits.
    Matej H
    Arch Immunol Ther Exp (Warsz); 1970; 18(3):315-26. PubMed ID: 4923030
    [No Abstract]   [Full Text] [Related]  

  • 40. Difference in the target cells for tolerance induction in relation to the dose of tolerogen.
    Katsura Y; Kawaguchi S; Muramatsu S
    Immunology; 1972 Oct; 23(4):537-44. PubMed ID: 4563476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.